Subscribe
shutterstock_1405481684_whitemocca
whiteMocca / Shutterstock.com
10 July 2019Big PharmaSarah Morgan

EU invests €35m into AI cancer diagnostics

The European Commission has pledged €35 million ($39.2 million) to promote the development of analysis of health images for cancer diagnostics, based on artificial intelligence (AI).

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
UK life sciences partnership to use AI in disease detection
5 December 2018   The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.
Americas
Chinese company fund invests in AI specialist
13 June 2018   China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.
Asia
Insilico Medicine signs $200m AI drug discovery deal
10 October 2019   Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Big Pharma
UK life sciences partnership to use AI in disease detection
5 December 2018   The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.
Americas
Chinese company fund invests in AI specialist
13 June 2018   China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.
Asia
Insilico Medicine signs $200m AI drug discovery deal
10 October 2019   Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.

More on this story

Big Pharma
UK life sciences partnership to use AI in disease detection
5 December 2018   The UK government and the life sciences industry have partnered to develop new technology using artificial intelligence to detect diseases at an early stage.
Americas
Chinese company fund invests in AI specialist
13 June 2018   China-based pharmaceutical technology company WuXi AppTec has partnered with artificial intelligence specialist Insilico Medicine to integrate Insilico’s AI technology with WuXi’s laboratory infrastructure.
Asia
Insilico Medicine signs $200m AI drug discovery deal
10 October 2019   Hong Kong-based Insilico Medicine has agreed an artificial intelligence breast cancer drug discovery partnership worth a potential $200 million with a Chinese pharmaceutical company.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent